MariMed Inc. (MRMD) stock
MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
$0.06−0.00 (-3.39%)
Close on Oct 19, 2026Market cap $22.97MP/E –Yield –
MariMed total assets
Total assets on the balance sheet at the end of each period.
MariMed's total assets was $198.31M at Sep 30, 2026. For fiscal 2025 it was $202.57M, down 2.1% from the year before. Over ten years it grew 49.2% a year on average. The highest annual figure on record is $206.99M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $202.57M | -2.1% |
| FY2024 | Dec 31, 2024 | $206.99M | +5.5% |
| FY2023 | Dec 31, 2023 | $196.12M | +28.9% |
| FY2022 | Dec 31, 2022 | $152.20M | +23.5% |
| FY2021 | Dec 31, 2021 | $123.21M | +61.2% |
| FY2020 | Dec 31, 2020 | $76.45M | +24.2% |
| FY2019 | Dec 31, 2019 | $61.57M | -25.8% |
| FY2018 | Dec 31, 2018 | $82.96M | +157.6% |
| FY2017 | Dec 31, 2017 | $32.20M | +276.1% |
| FY2016 | Dec 31, 2016 | $8.56M | +130.3% |
| FY2015 | Dec 31, 2015 | $3.72M | +125.0% |
| FY2014 | Dec 31, 2014 | $1.65M | 0.0% |
| FY2013 | Dec 31, 2013 | $1.65M | +1256.2% |
| FY2012 | Dec 31, 2012 | $121.84K | -35.9% |
| FY2011 | Dec 31, 2011 | $190.05K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $198.31M | -3.5% |
| Q2 FY2026 | Jun 30, 2026 | $197.23M | -3.5% |
| Q1 FY2026 | Mar 31, 2026 | $201.19M | -3.3% |
| Q4 FY2025 | Dec 31, 2025 | $202.57M | -2.1% |
| Q3 FY2025 | Sep 30, 2025 | $205.60M | -3.3% |
| Q2 FY2025 | Jun 30, 2025 | $204.37M | -2.0% |
| Q1 FY2025 | Mar 31, 2025 | $208.00M | +3.3% |
| Q4 FY2024 | Dec 31, 2024 | $206.99M | +5.5% |
| Q3 FY2024 | Sep 30, 2024 | $212.68M | +11.5% |
| Q2 FY2024 | Jun 30, 2024 | $208.53M | +10.1% |
| Q1 FY2024 | Mar 31, 2024 | $201.33M | +9.2% |
| Q4 FY2023 | Dec 31, 2023 | $196.12M | +28.9% |
| Q3 FY2023 | Sep 30, 2023 | $190.82M | +31.9% |
| Q2 FY2023 | Jun 30, 2023 | $189.37M | +39.4% |
| Q1 FY2023 | Mar 31, 2023 | $184.39M | +34.6% |
| Q4 FY2022 | Dec 31, 2022 | $152.20M | +23.5% |
| Q3 FY2022 | Sep 30, 2022 | $144.70M | +22.4% |
| Q2 FY2022 | Jun 30, 2022 | $135.88M | +51.0% |
| Q1 FY2022 | Mar 31, 2022 | $136.98M | +79.2% |
| Q4 FY2021 | Dec 31, 2021 | $123.21M | +70.1% |
| Q3 FY2021 | Sep 30, 2021 | $118.24M | +74.3% |
| Q1 FY2021 | Mar 31, 2021 | $89.98M | +37.7% |
| Q4 FY2020 | Dec 31, 2020 | $76.45M | +24.2% |
| Q3 FY2020 | Sep 30, 2020 | $72.45M | -47.1% |
| Q2 FY2020 | Jun 30, 2020 | $67.83M | -49.3% |
| Q1 FY2020 | Mar 31, 2020 | $65.34M | -33.1% |
| Q4 FY2019 | Dec 31, 2019 | $61.57M | -25.8% |
| Q3 FY2019 | Sep 30, 2019 | $137.06M | +139.9% |
| Q2 FY2019 | Jun 30, 2019 | $133.68M | +194.2% |
| Q1 FY2019 | Mar 31, 2019 | $97.63M | +187.7% |
| Q4 FY2018 | Dec 31, 2018 | $82.96M | +157.6% |
| Q3 FY2018 | Sep 30, 2018 | $57.13M | +167.3% |
| Q2 FY2018 | Jun 30, 2018 | $45.44M | +196.0% |
| Q1 FY2018 | Mar 31, 2018 | $33.94M | +212.8% |
| Q4 FY2017 | Dec 31, 2017 | $32.20M | +276.1% |
| Q3 FY2017 | Sep 30, 2017 | $21.37M | +177.7% |
| Q2 FY2017 | Jun 30, 2017 | $15.35M | – |
| Q1 FY2017 | Mar 31, 2017 | $10.85M | – |
| Q4 FY2016 | Dec 31, 2016 | $8.56M | – |
| Q3 FY2016 | Sep 30, 2016 | $7.70M | – |
See a number that looks wrong?